Tag Archive for 'biotechnology news'
March 10th, 2011 by admin
Many developing countries are fighting the battle against malaria, with thousands of people dying every year due to malaria. Now, new research from the University of Maryland has indicated that a genetically engineered fungus might actually be able to cure malaria. The research team has proposed that a genetically engineered fungus carrying genes for [...]
March 10th, 2011 by admin
In a breakthrough in neonatal technology, research has proved that the heart muscles of a newborn baby have the ability to grow back on its own. This promising discovery was revealed by researchers at the UT Southwestern Medical Center, who discovered that the mammalian newborn heart can heal itself completely.
March 9th, 2011 by admin
New research from the Virginia Bioinformatics Institute (VBI) has proven that there are very specific changes in the genetic makeup of people suffering from cancer and those who don’t have cancer. The researchers from VBI have developed a new technology that catches these genetic changes, which help in differentiating cancer patients from healthy individuals. The [...]
March 8th, 2011 by admin
BrainStorm Cell Therapeutics Inc., a major manufacturer of adult stem cell technologies and therapeutics, has recently announced how with the use of its NurOwn™ technology platform, it has developed a way in which intramuscular transplantation of autologous, astrocyte-like cells that manufacture and secrete neurotrophic factors (NTFs), preserved motor function, preserved the myelinated motor axons in [...]
March 4th, 2011 by admin
Fast Company has surveyed the biotech world and come up with its list of the Top 10 companies in the industry. Amyris makes the list for its work combating the malaria parasite, while Galapagos and Fate Therapeutics get nods for pipeline innovation.
March 3rd, 2011 by admin
Medco Health Solutions Inc’s (MHS.N) quarterly profit rose 11 percent on increased mail deliveries of generic drugs, but its shares fell as the report failed to excite investors. The U.S. pharmacy benefit manager reported a fourth-quarter profit, excluding special items, that matched Wall Street’s target and it backed its 2011 forecast. Its shares fell 4.5 [...]
March 3rd, 2011 by admin
U.S. medical researchers are using modified printers to produce skin for burn victims, the project’s leader says. “We started out by taking a typical desktop inkjet cartridge. Instead of ink we use cells, which are placed in the cartridge,” Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, N.C., told [...]
March 2nd, 2011 by admin
Two U.S. senators have revived the reimportation debate with a new bill co-sponsored by a bipartisan group of their fellows. Sen. Debbie Stabenow (D-Michigan) is teaming up with Sen. Olympia Snowe (R-Maine) on the proposal, which would allow U.S. pharmacies and drug wholesalers to source products from other countries with “tough safety standards.”
March 2nd, 2011 by admin
Adding to its store of technology weapons, Catalent Pharma can now offer fast-dissolve tablet technology to clients. It obtained the development rights to Lyopan from Pantec. The lyophilized tablets are used for such OTC products as allergy treatments and travel medications, says Catalent. The technology uses less water than other oral dose technologies, reducing not [...]
March 1st, 2011 by admin
Zymes, a New Jersey-based biopharmaceutical company, has received a two-year $476,000 grant from the Michael J Fox Foundation (MJFF), under the Therapeutics Development Initiative Fall 2010 Program, to evaluate the effectiveness of WS-CoQ10 in stopping the progressive loss of dopamine nerve cells in animal models of Parkinson’s disease (PD).